RxDoctor Payments Data

Heidi Hansen

Vascular Surgery · Lincoln, NENPI 1184052458

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,689 of the $2,542 with a category attached, or 66.5%. It is spread thinly across 33 manufacturers, the largest accounting for just 20.6%. Reporting peaked in 2023 at $725 and has fallen 67.3% since, to $237 in 2025. That places this record below the midpoint for vascular surgery clinicians in NE, where the typical reported total is $4,193.

$2,542in general payments, 2019–2025

Across 75 payments — averaging $33.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$524
  • Cook Medical LLC$434
  • Silk Road Medical, Inc.$235
  • Inari Medical, Inc.$198
  • Boston Scientific$115
  • Shockwave Medical, Inc$93
  • plus $942 from 27 others

What the payments were for

  • Travel & lodging$85334%
  • Food & beverage$1,68966%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,542 in reported general payments places this provider in the 35th percentile of 35 vascular surgery providers in Nebraska.

See all vascular surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$183,159
Medicare patients
890
Services billed
2,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate263$2,016
Cilostazol53$595
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen17$130
Atorvastatin Calcium11$108
Rosuvastatin Calcium12$37

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →